Spectral Medical Inc. (EDT)
TSX
Closed
Aug 25, 2026
Day's Range
1.3252 wk Range
1.21Overview - EDT - Spectral Medical Inc.
Key Statistics
Valuation
Enterprise Value
417.28M
P/E (Trailing)
‪-8.43‬
P/E (Forward)
‪67.00‬
Price / Sales (TTM)
‪153.11‬
Price / Book
‪-5.65‬
EV / EBITDA
‪-40.34‬
Profitability
Gross Margin
‪44.28%‬
Profit Margin
‪54.29%‬
Operating Margin
‪-338.64%‬
Return on Assets
‪-150.77%‬
Return on Equity
‪68.40%‬
Ownership
Shares Outstanding
293.41M
Float
288.34M
Held by Insiders
‪17.19%‬
Held by Institutions
‪12.43%‬
Price stats
Beta
‪0.20‬
50-Day Avg
‪1.37‬
200-Day Avg
‪1.36‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪CA$ 3.15‬Market Cap - EDT - Spectral Medical Inc.
Peers - EDT - Spectral Medical Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on TSX.
- EDTTSXSpectral Medical Inc.410.78MMarket Cap+20.00%52-week change-8.75P/E (Trailing)‪54.29%‬Profit Margin
- TMOTSXThermo Fisher Scientific CDR (CAD Hedged)309.42BMarket Cap+19.43%52-week change32.04P/E (Trailing)‪40.93%‬Profit Margin
- NEOTSXNeo Performance Materials Inc.1.53BMarket Cap+48.27%52-week change3484.00P/E (Trailing)‪0.25%‬Profit Margin
- PRMTSXBig Pharma Split Corp.20.86MMarket Cap+22.88%52-week change12.00P/E (Trailing)—Profit Margin
Profile Summary - EDT - Spectral Medical Inc.
About
Spectral Medical Inc. is a pioneering biotechnology company that focuses on developing innovative treatment solutions for critical care applications. The company's primary objective is to improve patient outcomes in sepsis management through its proprietary products like the Endotoxin Activity Assay (EAA) and the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
